Literature DB >> 10999546

Zonisamide reduces the increase in 8-hydroxy-2'-deoxyguanosine levels formed during iron-induced epileptogenesis in the brains of rats.

M Komatsu1, M Hiramatsu, L J Willmore.   

Abstract

PURPOSE: To examine the change of 8-hydroxy-2'deoxyguanosine (8-OHdG) levels, which are used as a marker for oxidative DNA damage, in iron-induced epileptogenic foci of the rat cerebrum.
METHOD: Male Wistar rats were given a cortical injection of ferric chloride, and their 8-OHdG levels were determined over time. Additional animals were pretreated with the antiepileptic drug zonisamide (ZNS) before the ferric chloride injection, and their 8-OHdG levels were compared with the nonpretreated rats.
RESULTS: Fifteen minutes after ferric chloride solution injection, the level of 8-OHdG increased, reaching a maximum 30 minutes after injection. Sixty minutes after injection, the levels coincided with those of controls. ZNS, in concentrations of 50 and 100 mg/kg body weight, prevented the increase of 8-OHdG levels within the cerebrum 30 minutes after iron solution injection.
CONCLUSIONS: These results indicate that the formation of iron-induced epileptogenic foci in rats is related to DNA-damage-induced reactive oxygen species and that the inhibition of 8-OHdG formation by ZNS after iron injection may be due to the drug's antioxidant activity. The data suggest that free radical species known to be formed during iron salts-induced focal epileptogenesis cause damage to isocortical DNA. Furthermore, ZNS appears to inhibit the focal injuring response to DNA that occurs following iron salts-induced acute epileptogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999546     DOI: 10.1111/j.1528-1157.2000.tb00312.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  14 in total

Review 1.  New antiepileptic drugs.

Authors:  C W Bazil
Journal:  Curr Neurol Neurosci Rep       Date:  2001-07       Impact factor: 5.081

Review 2.  A role for guanidino compounds in the brain.

Authors:  Midori Hiramatsu
Journal:  Mol Cell Biochem       Date:  2003-02       Impact factor: 3.396

Review 3.  Role of oxidative stress in epileptic seizures.

Authors:  Eun-Joo Shin; Ji Hoon Jeong; Yoon Hee Chung; Won-Ki Kim; Kwang-Ho Ko; Jae-Hyung Bach; Jau-Shyong Hong; Yukio Yoneda; Hyoung-Chun Kim
Journal:  Neurochem Int       Date:  2011-06-13       Impact factor: 3.921

Review 4.  Epilepsy and epileptic syndrome.

Authors:  Tomonori Ono; Aristea S Galanopoulou
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

5.  Zonisamide attenuates MPP+-induced oxidative toxicity through modulation of Ca2+ signaling and caspase-3 activity in neuronal PC12 cells.

Authors:  Vedat Ali Yürekli; Semih Gürler; Mustafa Nazıroğlu; Abdülhadi Cihangir Uğuz; Hasan Rifat Koyuncuoğlu
Journal:  Cell Mol Neurobiol       Date:  2012-11-15       Impact factor: 5.046

Review 6.  Posttraumatic epilepsy: hemorrhage, free radicals and the molecular regulation of glutamate.

Authors:  L J Willmore; Yuto Ueda
Journal:  Neurochem Res       Date:  2008-09-11       Impact factor: 3.996

7.  Zonisamide attenuates hyperoxia-induced apoptosis in the developing rat brain.

Authors:  Yasemin Topçu; Erhan Bayram; Seda Ozbal; Uluç Yiş; Kazım Tuğyan; Pakize Karaoğlu; Abdullah Kumral; Osman Yılmaz; Semra Hız Kurul
Journal:  Neurol Sci       Date:  2014-06-11       Impact factor: 3.307

8.  A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice.

Authors:  Ryohei Yano; Hironori Yokoyama; Hayato Kuroiwa; Hiroyuki Kato; Tsutomu Araki
Journal:  J Mol Neurosci       Date:  2009-02-07       Impact factor: 3.444

9.  Disease Modification in Epilepsy: Behavioural Accompaniments.

Authors:  Emilio Russo; Rita Citraro
Journal:  Curr Top Behav Neurosci       Date:  2022

10.  The role of reactive species in epileptogenesis and influence of antiepileptic drug therapy on oxidative stress.

Authors:  Boštjan Martinc; Iztok Grabnar; Tomaž Vovk
Journal:  Curr Neuropharmacol       Date:  2012-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.